Список акций индустрии Drug Manufacturers—General
Доходность с начала года
< 0.0%
—
> 10.0%
Доходность за 10 лет
< 0.0%
—
> 10.0%
Коэф-т Шарпа
< 0.0
—
> 0.1
Коэф-т Омега
< 0.0
—
> 0.1
Коэф-т Сортино
< 0.0
—
> 0.1
Коэф-т Кальмара
< 0.0
—
> 0.1
Индекс Язвы
< 0.0%
—
> 10.0%
Вол-ть за 10 лет
< 0.0%
—
> 10.0%
Максимальная просадка
< 0.0%
—
> 10.0%
Дивидендный доход
< 0.0%
—
> 10.0%
| Тикер | Название | Дох-ть с нач. г. | Дох-ть за 10 лет | Див. доход | Вол-ть за 10 лет | Макс. просадка | Коэф-т Шарпа | Коэф-т Сортино | Коэф-т Омега | Коэф-т Кальмара | Индекс Язвы |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1093.HK | CSPC Pharmaceutical Group Ltd | -12.6% | 12.4% | 3.6% | 39.4% | -83.7% | -0.8 | -1.0 | 0.9 | -0.6 | 29.0% |
| 2186.HK | Luye Pharma Group Ltd | 7.9% | N/A | 0.0% | 44.4% | -81.7% | 0.9 | 1.6 | 1.2 | 1.0 | 18.3% |
| ABBOTINDIA.NS | Abbott India Limited | 13.2% | 33.4% | 0.6% | 26.2% | -73.3% | 1.3 | 2.0 | 1.2 | 2.2 | 5.1% |
| ABBV | AbbVie Inc. | -10.5% | 15.8% | 4.3% | 26.8% | -45.1% | -0.5 | -0.6 | 0.9 | -0.5 | 10.3% |
| AMGN | Amgen Inc. | 4.1% | 11.8% | 3.2% | 24.7% | -78.0% | -0.2 | -0.2 | 1.0 | -0.1 | 13.5% |
| AZN | AstraZeneca PLC | -4.1% | 12.2% | 2.3% | 25.2% | -48.9% | -0.1 | 0.1 | 1.0 | -0.1 | 8.2% |
| AZN.L | AstraZeneca plc | -9.2% | 14.9% | 0.0% | 24.5% | -50.0% | -0.3 | -0.2 | 1.0 | -0.4 | 9.4% |
| BAYN.DE | Bayer Aktiengesellschaft | -31.6% | -7.6% | 7.6% | 28.9% | -80.9% | -1.4 | -1.7 | 0.7 | -0.8 | 16.5% |
| BAYRY | Bayer AG PK | -30.4% | -9.6% | 7.3% | 29.5% | -69.3% | -1.2 | -1.4 | 0.8 | -0.8 | 16.5% |
| BIIB | Biogen Inc. | -17.4% | -1.6% | 0.0% | 42.9% | -90.0% | -1.1 | -1.5 | 0.8 | -0.8 | 13.6% |
| BMY | Bristol-Myers Squibb Company | -29.4% | 2.5% | 4.7% | 24.1% | -70.6% | -1.9 | -2.6 | 0.7 | -0.9 | 19.9% |
| CIPLA.NS | Cipla Limited | 12.2% | 12.7% | 0.7% | 27.0% | -86.5% | 0.4 | 0.6 | 1.1 | 0.4 | 12.2% |
| DPH.L | Dechra Pharmaceuticals plc | 46.7% | 20.3% | 0.0% | 29.1% | -78.1% | 0.9 | 2.0 | 1.4 | 2.0 | 7.3% |
| GILD | Gilead Sciences, Inc. | -10.2% | 2.9% | 4.0% | 26.7% | -70.8% | -0.4 | -0.5 | 0.9 | -0.6 | 9.4% |
| GLAND.NS | Gland Pharma Limited | 11.4% | N/A | 0.0% | 43.4% | -79.3% | 0.0 | 0.3 | 1.0 | 0.0 | 28.3% |
| GRF.MC | Grifols S.A | 21.8% | -1.6% | 0.0% | 30.9% | -75.8% | 0.6 | 1.1 | 1.1 | 0.6 | 19.6% |
| GRFS | Grifols, S.A. | 15.2% | -4.0% | 0.0% | 33.3% | -75.9% | 0.5 | 1.1 | 1.1 | 0.5 | 18.1% |
| GSK | GlaxoSmithKline plc | 5.5% | 1.0% | 3.9% | 20.3% | -55.7% | 0.5 | 0.9 | 1.1 | 0.9 | 6.8% |
| GSK.L | GlaxoSmithKline plc | 2.3% | 3.6% | 0.0% | 20.0% | -50.1% | 0.3 | 0.7 | 1.1 | 0.4 | 6.2% |
| HZNP | Horizon Therapeutics Public Limited Company | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |